Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 See also 2 References

LY-2459989

Add links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version Appearance From Wikipedia, the free encyclopedia

LY-2459989
Clinical data

Routes of administration	Oral, intravenous
ATC code	None
Pharmacokinetic data
Elimination half-life	15 minutes (in rhesus monkeys)^[1]
Identifiers
IUPAC name 3-Fluoro-4-[4-[[(2S)-2-pyridin-3-ylpyrrolidin-1-yl]methyl]phenoxy]benzamide
CAS Number	2254067-61-1^Y
PubChem CID	134819873
UNII	2X23M5HP34
CompTox Dashboard (EPA)	DTXSID201045938
Chemical and physical data
Formula	C₂₃H₂₂FN₃O₂
Molar mass	391.446 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES NC(=O)c1ccc(Oc2ccc(CN3CCC[C@H]3c4cccnc4)cc2)c(F)c1
InChI InChI=1S/C23H22FN3O2/c24-20-13-17(23(25)28)7-10-22(20)29-19-8-5-16(6-9-19)15-27-12-2-4-21(27)18-3-1-11-26-14-18/h1,3,5-11,13-14,21H,2,4,12,15H2,(H2,25,28)/t21-/m0/s1 Key:DRGHCUTTXWIERB-NRFANRHFSA-N

LY-2459989 is a silent antagonist of the κ-opioid receptor (KOR) that has been developed by Eli Lilly as a radiotracer of that receptor, labeled either with carbon-11^[1]orfluorine-18.^[2] It possesses high affinity for the KOR (K_i = 0.18 nM) and is highly selective for it over the μ-opioid receptor (K_i = 7.68 nM) and the δ-opioid receptor (K_i = 91.3 nM) (over 43-fold selectivity for the KOR over the other opioid receptors).^[1] LY-2459989 is a fluorine-containing analogue and follow-up compound of LY-2795050, the first KOR-selective antagonist radiotracer.^[1] Relative to LY-2795050, LY-2459989 displays 4-fold higher affinity for the KOR and similar selectivity and also possesses greatly improved central nervous system permeation (brain levels were found to be 6-fold higher than those of LY-2795050).^[1] The drug appears to possess a short duration of action, with only 25% remaining in serum at 30 minutes post-injection in rhesus monkeys, making it an ideal agent for application in biomedical imaging, for instance in positron emission tomography (PET).^[1]

Earlier analogues of LY-2459989 besides LY-2795050 with similar actions and potential uses have also been described.^[3]

References[edit]

^ ^a ^b ^c ^d ^e ^f Zheng MQ, Kim SJ, Holden D, Lin SF, Need A, Rash K, Barth V, Mitch C, Navarro A, Kapinos M, Maloney K, Ropchan J, Carson RE, Huang Y (2014). "An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989". J. Nucl. Med. 55 (7): 1185–91. doi:10.2967/jnumed.114.138701. PMC 4826283. PMID 24854795.

^ Cai Z, Li S, Pracitto R, Navarro A, Shirali A, Ropchan J, Huang Y (2017). "Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors". ACS Chem Neurosci. 8 (1): 12–16. doi:10.1021/acschemneuro.6b00268. PMID 27741398.

^ Mitch CH, Quimby SJ, Diaz N, Pedregal C, de la Torre MG, Jimenez A, Shi Q, Canada EJ, Kahl SD, Statnick MA, McKinzie DL, Benesh DR, Rash KS, Barth VN (2011). "Discovery of aminobenzyloxyarylamides as κ opioid receptor selective antagonists: application to preclinical development of a κ opioid receptor antagonist receptor occupancy tracer". J. Med. Chem. 54 (23): 8000–12. doi:10.1021/jm200789r. PMID 21958337.